Literature DB >> 6320777

Ribonucleic acids of Machupo and Lassa viruses.

I S Lukashevich, T A Stelmakh, V P Golubev, E P Stchesljenok, N N Lemeshko.   

Abstract

Sucrose gradient velocity centrifugation, polyacrylamide gel electrophoresis and RNA-RNA hybridization were used to characterize Lassa and Machupo virion RNAs as well as virus-specific RNAs from cells infected with Pichinde and Machupo viruses. Five RNA species: 30-31S, 28S, 22-24S, 18S and 4-6S have been detected in Lassa, Machupo, and Pichinde virion RNAs. Among them 28S, 18S and 4-6S RNAs cosediment and comigrate with respectively cell RNAs. RNase resistance analyses suggest the presence of extensive secondary structures and complementary RNAs in Lassa, Machupo, and Pichinde virion RNAs. Annealing with poly(A)-containing RNA from infected cells has revealed that the bulk of "minus" strands of Machupo virion RNA is located in 22-24S and 28-31S fractions of sucrose gradient. Thus Machupo and Lassa viruses as well as Pichinde virus contain two genomic RNA fragments: "large" (molecular weight of about 2.2 X 10(6] and "small" (molecular weight of about 1.3 X 10(6]. In the cells infected with Pichinde virus and treated with actinomycin D (1.0 microgram/ml) synthesis of 18S, 22-24S and 30-31S RNAs has been registered. At least 22-24S and 30-31S classes comprise "plus" and "minus" strands. In cells infected with Machupo virus in the presence of actinomycin D the synthesis of similar sedimentation classes of RNAs and certain amounts of 28S RNA have been detected.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6320777     DOI: 10.1007/bf01310811

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  18 in total

1.  Rapid isolation of antigens from cells with a staphylococcal protein A-antibody adsorbent: parameters of the interaction of antibody-antigen complexes with protein A.

Authors:  S W Kessler
Journal:  J Immunol       Date:  1975-12       Impact factor: 5.422

2.  A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels.

Authors:  W M Bonner; R A Laskey
Journal:  Eur J Biochem       Date:  1974-07-01

3.  Inhibition of lymphocytic choriomeningitis virus replication by actinomycin D and 6-azauridine.

Authors:  L L Buck; C J Pfau
Journal:  Virology       Date:  1969-04       Impact factor: 3.616

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Formation and characterization of an intertypic lymphocytic choriomeningitis recombinant virus.

Authors:  W E Kirk; P Cash; C J Peters; D H Bishop
Journal:  J Gen Virol       Date:  1980-11       Impact factor: 3.891

6.  Lymphocytic choriomeningitis virus RNAs.

Authors:  I R Pedersen
Journal:  Nat New Biol       Date:  1971-11-24

7.  The effect of 5-iododeoxyuridine and actinomycin D on the multiplication of Junin virus.

Authors:  C E Coto; M D de Vombergar
Journal:  Arch Gesamte Virusforsch       Date:  1969

8.  Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose.

Authors:  H Aviv; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1972-06       Impact factor: 11.205

9.  Effects of actinomycin D and ultraviolet and ionizing radiation on Pichinde virus.

Authors:  M F Carter; F A Murphy; J P Brunschwig; C Noonan; W E Rawls
Journal:  J Virol       Date:  1973-07       Impact factor: 5.103

10.  Arenaviruses.

Authors:  J Casals
Journal:  Yale J Biol Med       Date:  1975-05
View more
  17 in total

1.  Replicon system for Lassa virus.

Authors:  Meike Hass; Uta Gölnitz; Stefanie Müller; Beate Becker-Ziaja; Stephan Günther
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

2.  Safety, immunogenicity, and efficacy of the ML29 reassortant vaccine for Lassa fever in small non-human primates.

Authors:  Igor S Lukashevich; Ricardo Carrion; Maria S Salvato; Keith Mansfield; Kathleen Brasky; Juan Zapata; Cristiana Cairo; Marco Goicochea; Gia E Hoosien; Anysha Ticer; Joseph Bryant; Harry Davis; Rasha Hammamieh; Maria Mayda; Marti Jett; Jean Patterson
Journal:  Vaccine       Date:  2008-08-08       Impact factor: 3.641

3.  The Lassa fever virus L gene: nucleotide sequence, comparison, and precipitation of a predicted 250 kDa protein with monospecific antiserum.

Authors:  I S Lukashevich; M Djavani; K Shapiro; A Sanchez; E Ravkov; S T Nichol; M S Salvato
Journal:  J Gen Virol       Date:  1997-03       Impact factor: 3.891

4.  L and S species of Machupo virion RNA contain a mixture of complementary strands. Brief report.

Authors:  I S Lukashevich; V P Golubev; E P Stcheslyenok; N N Finskaya; T A Stelmakh
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

5.  In vitro translation of mRNA species from cells infected with Machupo virus.

Authors:  I S Lukashevich; T A Stelmakh; E P Stchesljenok; T V Shkolina
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

6.  A live attenuated vaccine for Lassa fever made by reassortment of Lassa and Mopeia viruses.

Authors:  Igor S Lukashevich; Jean Patterson; Ricardo Carrion; Dmitry Moshkoff; Anysha Ticer; Juan Zapata; Kathleen Brasky; Robert Geiger; Gene B Hubbard; Joseph Bryant; Maria S Salvato
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

7.  Early events in arenavirus replication are sensitive to lysosomotropic compounds.

Authors:  S E Glushakova; I S Lukashevich
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

8.  Some biochemical properties of Lassa virus RNA and polypeptides.

Authors:  I S Lukashevich; N N Lemeshko; T A Stelmakh; V P Golubev; E P Stcheslyenok
Journal:  Med Microbiol Immunol       Date:  1986       Impact factor: 3.402

Review 9.  The search for animal models for Lassa fever vaccine development.

Authors:  Igor S Lukashevich
Journal:  Expert Rev Vaccines       Date:  2013-01       Impact factor: 5.217

10.  A ML29 reassortant virus protects guinea pigs against a distantly related Nigerian strain of Lassa virus and can provide sterilizing immunity.

Authors:  Ricardo Carrion; Jean L Patterson; Curtis Johnson; Monica Gonzales; Carmen R Moreira; Anysha Ticer; Kathleen Brasky; Gene B Hubbard; Dmitry Moshkoff; Juan Zapata; Maria S Salvato; Igor S Lukashevich
Journal:  Vaccine       Date:  2007-02-27       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.